702558 |
FRONTIERS IN ONCOLOGY |
Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead |
2021-06-14 |
10.3389/fonc.2021.694320 |
Shrestha Sumana, Morcavallo Alaide, Gorrini Chiara, Chesler Louis |
702557 |
FRONTIERS IN ONCOLOGY |
The Novel Curcumin Derivative 1g Induces Mitochondrial and ER-Stress-Dependent Apoptosis in Colon Cancer Cells by Induction of ROS Production |
2021-06-14 |
10.3389/fonc.2021.644197 |
Wang Hao, Xu Yingxing, Sun Jialin, Sui Zhongguo |
702556 |
FRONTIERS IN ONCOLOGY |
Fluorescein-Guided Panendoscopy for Head and Neck Cancer Using Handheld Probe-Based Confocal Laser Endomicroscopy: A Pilot Study |
2021-06-14 |
10.3389/fonc.2021.671880 |
Dittberner Andreas, Ziadat Rafat, Hoffmann Franziska, Pertzborn David, Gassler Nikolaus, Guntinas-Lichius Orlando |
702555 |
FRONTIERS IN ONCOLOGY |
Implications of Habitual Alcohol Intake With the Prognostic Significance of Mean Corpuscular Volume in Stage II-III Colorectal Cancer |
2021-06-14 |
10.3389/fonc.2021.681406 |
Liu Qi, Yang Yufei, Li Xinxiang, Zhang Sheng |
702554 |
FRONTIERS IN ONCOLOGY |
The Challenge of Melanocytic Lesions in Pediatric Patients: Clinical-Pathological Findings and the Diagnostic Value of PRAME |
2021-06-14 |
10.3389/fonc.2021.688410 |
Umano Giuseppina Rosaria, Errico Maria Elena, D’Onofrio Vittoria, Delehaye Giulia, Trotta Letizia, Spinelli Claudio, Strambi Silvia, Franco Renato, D’Abbronzo Giuseppe, Ronchi Andrea, Papparella Alfonso |
702553 |
FRONTIERS IN ONCOLOGY |
Alteration of Cholesterol Metabolism by Metformin Is Associated With Improved Outcome in Type II Diabetic Patients With Diffuse Large B-Cell Lymphoma |
2021-06-14 |
10.3389/fonc.2021.608238 |
Jiang Xiang-Nan, Zhang Yan, Wang Wei-Ge, Sheng Dong, Zhou Xiao-Yan, Li Xiao-Qiu |
702552 |
FRONTIERS IN ONCOLOGY |
EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes |
2021-06-14 |
10.3389/fonc.2021.680804 |
Jin Rui, Peng Ling, Shou Jiawei, Wang Jin, Jin Yin, Liang Fei, Zhao Jing, Wu Mengmeng, Li Qin, Zhang Bin, Wu Xiaoying, Lan Fen, Xia Lixia, Yan Junrong, Shao Yang, Stebbing Justin, Shen Huahao, Li Wen, Xia Yang |
702551 |
FRONTIERS IN ONCOLOGY |
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade |
2021-06-14 |
10.3389/fonc.2021.684110 |
Nardone Valerio, Giannicola Rocco, Bianco Giovanna, Giannarelli Diana, Tini Paolo, Pastina Pierpaolo, Falzea Antonia Consuelo, Macheda Sebastiano, Caraglia Michele, Luce Amalia, Zappavigna Silvia, Mutti Luciano, Pirtoli Luigi, Giordano Antonio, Correale Pierpaolo |
702550 |
FRONTIERS IN ONCOLOGY |
Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Date in China |
2021-06-14 |
10.3389/fonc.2021.665217 |
Han Xiaoyan, Jin Chunxiang, Zheng Gaofeng, He Donghua, Zhao Yi, Li Yi, Wu Wenjun, Zheng Weiyan, Wei Guoqing, Zhang Enfan, Huang He, He Jingsong, Cai Zhen |
702549 |
FRONTIERS IN ONCOLOGY |
A Tumor Progression Related 7-Gene Signature Indicates Prognosis and Tumor Immune Characteristics of Gastric Cancer |
2021-06-14 |
10.3389/fonc.2021.690129 |
Liu Fen, Yang Zongcheng, Zheng Lixin, Shao Wei, Cui Xiujie, Wang Yue, Jia Jihui, Fu Yue |